Prescription drug · ANDA
methazolamide NDC 0574-0791
Methazolamide 50 mg/1 · Tablet · Oral · Padagis US LLC
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- methazolamide
- Generic name (nonproprietary)
- methazolamide
- Active ingredients
- Methazolamide — 50 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- Padagis US LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040062
- Marketing start
- Marketing end
- Identifiers
- Product ID 0574-0791_94b58ed4-5a45-4777-924c-7608156be1b0SPL ID 94b58ed4-5a45-4777-924c-7608156be1b0SPL set ID 5e0795e1-d5c5-4b04-9bce-077bb8028023RxCUI 197939, 197940UNII W733B0S9SDUPC 0305740790014, 0305740791011
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE: Methazolamide Tablets USP is indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where lowering the intraocular pressure is desired before surgery.
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 040062
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| methazolamide | Methazolamide 25 mg/1 | TabletOral | Padagis US LLC | 0574-0790 |